The Impact of Instant Reimbursement of Cross-Regional Medical Services on Hospitalization Costs Incurred by the Floating Population—Evidence from China

The Impact of Instant Reimbursement of Cross-Regional Medical Services on Hospitalization Costs Incurred by the Floating Population—Evidence from China

Background: The medical cost reimbursement function of medical insurance can reduce the medical burden of individuals and thus improve their medical service utilization level. This study aimed to explore the impact of different cross-regional reimbursement types of medical insurance (instant reimbur...

Full description

Bibliographic Details
Main Authors:	Xiaodong Zhang, Lei Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Healthcare
Subjects:	medical insurance instant reimbursement manual reimbursement hospitalization costs floating population
Online Access:	https://www.mdpi.com/2227-9032/10/6/1099

Similar Items

Does the immediate reimbursement of medical insurance reduce the socioeconomic inequality in health among the floating population? Evidence from China
by: Wen He
Published: (2023-05-01)

THE PROCEDURE OF REIMBURSEMENT OF THE COSTS INCURRED IN A TRIAL, IN A SUBSEQUENT TRIAL
by: Georgiana COMAN
Published: (2022-06-01)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
by: Lauren K. Lemke, et al.
Published: (2023-08-01)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, et al.
Published: (2010-01-01)

The timelines for the price and reimbursement authorization in Italy 2018–2020
by: Valentina Gallo, et al.
Published: (2022-12-01)

Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
by: Claudio Jommi, et al.
Published: (2022-09-01)

Reimbursement measures in European countries – findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015-12-01)

The effect of trans-provincial immediate reimbursement for healthcare expenses on inequity in the utilization of healthcare services for migrants
by: Mei Zhou, et al.
Published: (2024-03-01)

Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017-12-01)

What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01)

Effect of retirement on medical reimbursement expenses—evidence from China
by: Yuanyang Wu, et al.
Published: (2023-04-01)

Equivalent Modes of Reimbursement in Augmented Contests
by: Chen Cohen, et al.
Published: (2023-03-01)

The Impact of the Clinical Miscoding on Inpatient Reimbursement
by: Roghayeh Ershad Sarabi, et al.
Published: (2020-03-01)

Reimbursement of care for severe trauma under SwissDRG
by: Rudolf M Moos, et al.
Published: (2016-08-01)

The History of Reimbursements in Neurology
by: Shaheen E Lakhan, et al.
Published: (2013-11-01)

Analysis of changes in drug reimbursement based on the example of the limit groups containing beta-2 adrenergic drugs in Poland in the years 2012-2021
by: Piotr Zbigniew Rykowski, et al.
Published: (2022-06-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria
by: Georgi Iskrov, et al.
Published: (2016-02-01)

Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
by: Przemysław Kardas, et al.
Published: (2022-08-01)

Trends in Medicare utilization and reimbursement for wound debridement procedures 2012–2017
by: Pranav Puri, et al.
Published: (2022-02-01)

THEORETICAL AND PRACTICAL ASPECTS REGARDING THE ADJUSTMENT AND REIMBURSEMENT OF VALUE ADDED TAX
by: CIUMAG MARIN, et al.
Published: (2021-10-01)

Female patients with rheumatoid arthritis – hospitalisation costs
by: Luana Andreea Macovei, et al.
Published: (2019-12-01)

Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study
by: Tamás Ágh, et al.
Published: (2022-06-01)

The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer
by: Sarah Sharman Moser, et al.
Published: (2023-02-01)

Personalized Medicine’s Bottleneck: Diagnostic Test Evidence and Reimbursement
by: Joshua P. Cohen, et al.
Published: (2014-04-01)

Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
by: Virginia Ronco, et al.
Published: (2021-12-01)

Introduction of medical products into healthcare practice and costs reimbursement: European experience
by: V. V. Omelyanovsky, et al.
Published: (2018-08-01)

Environmental Insurance: Insurable Risks and Losses Subject to Compensation
by: Yury A. Spletukhov
Published: (2023-04-01)

Research on the influence of patient cost-sharing on medical expenses and health outcomes: Taking patients with heart failure as an example
by: Huyang Zhang, et al.
Published: (2023-03-01)

Impact of alternative reimbursement strategies in the new cooperative medical scheme on caesarean delivery rates: a mixed-method study in rural China
by: Huang Kun, et al.
Published: (2012-07-01)

Pressure ulcers in German hospitals: Analysis of reimbursement and length of stay
by: Lahmann Nils, et al.
Published: (2024-02-01)

Current Status of Pathologic Examinations in Korea, 2011–2015, Based on the Health Insurance Review and Assessment Service Dataset
by: Sun-ju Byeon
Published: (2017-03-01)

Analysis of the current status and influencing factors of cross-regional hospitalization services utilization by basic medical insurance participants in China − taking a central province as an example
by: Tianyu Song, et al.
Published: (2023-12-01)

Reimbursement decision-making system in Poland systematically compared to other countries
by: Aneta Mela, et al.
Published: (2023-10-01)

The cost of dialysis renal replacement therapy for end-stage renal disease patients in Ukraine
by: M. Kolesnyk, et al.
Published: (2019-12-01)

Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies
by: Mihajlo Jakovljevic, et al.
Published: (2017-09-01)

Reimbursement of care does not equal the distribution of hospital resources: an explorative case study on a missing link among Dutch hospitals
by: L. V. L. van Leeuwen, et al.
Published: (2023-09-01)

A physician led approach to telehealth-enabled care coordination: innovation in reimbursement and delivery system models to support physician engagement
by: Ileana Welte
Published: (2012-06-01)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023-12-01)